Bennett H, Tank A, Evans M, Bergenheim K, et al. Cost-effectiveness of dapagliflozin as an adjunct to insulin for the treatment of Type 1 Diabetes Mellitus in the UK. Diabetes Obes Metab 2020 Feb 9. doi: 10.1111/dom.13992.
PMID: 32037675